Literature DB >> 25203014

Sanofi to propel inhalable insulin Afrezza into market.

Jim Kling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25203014     DOI： 10.1038/nbt0914-851a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  Pfizer dumps Exubera.

Authors:  George S Mack
Journal:  Nat Biotechnol       Date:  2007-12       Impact factor: 54.908

2.  Dreamboat sinks prospects for fast approval of inhaled insulin.

Authors:  Jim Kling
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908
  2 in total
  4 in total

Review 1.  Non-invasive delivery strategies for biologics.

Authors:  Aaron C Anselmo; Yatin Gokarn; Samir Mitragotri
Journal:  Nat Rev Drug Discov       Date:  2018-11-30       Impact factor: 84.694

2.  Biopharmaceutical benchmarks 2014.

Authors:  Gary Walsh
Journal:  Nat Biotechnol       Date:  2014-10       Impact factor: 54.908

Review 3.  Pursuit of a perfect insulin.

Authors:  Alexander N Zaykov; John P Mayer; Richard D DiMarchi
Journal:  Nat Rev Drug Discov       Date:  2016-03-18       Impact factor: 84.694

4.  Targeted Phage Display-based Pulmonary Vaccination in Mice and Non-human Primates.

Authors:  Daniela I Staquicini; E Magda Barbu; Rachel L Zemans; Beth K Dray; Fernanda I Staquicini; Prashant Dogra; Marina Cardó-Vila; Cindy K Miranti; Wallace B Baze; Luisa L Villa; Jorge Kalil; Geetanjali Sharma; Eric R Prossnitz; Zhihui Wang; Vittorio Cristini; Richard L Sidman; Andrew R Berman; Reynold A Panettieri; Rubin M Tuder; Renata Pasqualini; Wadih Arap
Journal:  Med (N Y)       Date:  2020-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.